Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
在 1 岁生日时检测 ASD 作为护理标准:Get SET Early 模型
基本信息
- 批准号:9611999
- 负责人:
- 金额:$ 5.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-25 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:1 year oldAgeAmericasAutistic DisorderBiological ModelsCDC2 geneCenters for Disease Control and Prevention (U.S.)CharacteristicsChildChildhoodCitiesClinicClinicalDataDatabasesDetectionDevelopmentDevelopmental Delay DisordersDiagnosisDiagnosticEarly DiagnosisEarly InterventionEarly treatmentEnsureEvaluationGuidelinesHabitsHouseholdIncomeLifeLos AngelesMeasuresMedicalModelingNotificationOnline SystemsOutcome MeasureParentsPerformanceReportingResearchRiskScheduleScreening procedureSensitivity and SpecificityServicesSiteSpeedStandardizationSurveysSystemTelephoneTestingToddlerTreatment outcomeUnited States Dept. of Health and Human Servicesbasebrain cellcatalystcheckup examinationclinical practicecohortdata sharingdesigndigitalearly screeningfollow-upimprovedinnovationmedical specialtiesmemberpediatricianprimary outcomeprogramsprospectiveprovider networkspublic health relevanceresearch studysatisfactionscreeningstandard of care
项目摘要
DESCRIPTION (provided by applicant): We previously demonstrated that our early intervention model system, which was centered on using the CSBS to screen all babies at the 1-year check-up as standard of care, resulted in a mean age of 12 months for screening, 14 months for evaluation, and 18 months for treatment participation. These are far younger ages than is common in the U.S. Our 3-stage model system, Get SET (S=Screen; E=Evaluate; T=Treat) Early, screened >10,000 1 year olds in our first trial run1 detecting over 100 ASD and other developmental delayed toddlers. We will build on this highly effective model by implementing a new version in two major cities: San Diego and Phoenix; Los Angeles, Irvine, and Phoenix will provide baseline control data. In Phoenix, we test the feasibility of establishing
the Get SET Early model in a city with one of the lowest median incomes and oldest age of first diagnosis in America. In AIM #1, the Screen and Refer Early stage, we will create a Pediatrician Network with 100 members. In San Diego we will utilize our existing Pediatrician Network and test new innovations such as a repeat triple screen at 12, 18, and 24 months to ensure that no toddlers are missed. Speed of referral for evaluation will be compared and contrasted using parent (self) and automatic (referral i- Pad App) options. We will track every toddler with an eventual ASD diagnosis within circumscribed medical groups to determine the true sensitivity and specificity of the screening tool and the percentage of ASD toddlers detected by our model. Anonymous survey data regarding screening habits will be administered to parents and pediatricians. AIM #2 implements the Evaluate and Refer Early stage. Its key attribute is an ASD Early Evaluation Clinic that specializes in the rapid scheduling and evaluation of every referred screened positive toddler. Toddlers will enter the program at the age they fail the screen (i.e., 12, 18 or 24 months) and will be thoroughly diagnostically evaluated and tracked once per year until they turn 3 years. This specialty Clinic is at our Autism Center in San Diego and will be developed at SARRC in Phoenix. Automated versus optional self-referral for treatment will be tested and compared. AIM #3 implements the Treat Early stage. Its key attributes are a network of providers of empirically based treatment and the innovative use of an inexpensive and readily available web-based treatment tracking system to document engagement. Treatment Networks will be created in San Diego and Phoenix. Primary outcome measures include rates and ages of screening and referral, evaluation and referral, and treatment engagement; sustainability across years; diagnostic, clinical and demographic characteristics of subjects; professional and parent satisfaction at each stage. We hypothesize that providing screening tools with clear cut-off scores and guidelines for automatic referral for evaluation and treatment, will result in dramatically lowering mean age of diagnosis and treatment in Phoenix from 4-5 years down to 1-2 years; San Diego will likewise have mean ages of 1-2 years for diagnosis and treatment making them significantly earlier than Los Angeles and Irvine control sites.
描述(由申请人提供):我们之前证明了我们的早期干预模型系统,该系统以使用CSBS在1岁检查时对所有婴儿进行筛查为中心,作为标准护理,结果显示筛查的平均年龄为12个月,评估的平均年龄为14个月,参与治疗的平均年龄为18个月。这些孩子的年龄比美国的普遍年龄要小得多。我们的三阶段模型系统Get SET (S=筛查;E=评估;T=治疗)早期,在我们的第一次试验中筛查了100多万名1岁儿童,发现了100多名ASD和其他发育迟缓的幼儿。我们将在这一高效模式的基础上,在两个主要城市实施新版本:圣地亚哥和凤凰城;洛杉矶、尔湾和凤凰城将提供基线控制数据。在凤凰城,我们测试了建立的可行性
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen L Pierce其他文献
Karen L Pierce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen L Pierce', 18)}}的其他基金
Testing the accuracy of eye tracking as a screening tool for ASD in the general population
测试眼动追踪作为普通人群自闭症谱系障碍筛查工具的准确性
- 批准号:
10638066 - 财政年份:2023
- 资助金额:
$ 5.63万 - 项目类别:
1/2-Testing the impact of early screening on the long-term outcomes of children with ASD
1/2-测试早期筛查对自闭症儿童长期结果的影响
- 批准号:
10543107 - 财政年份:2020
- 资助金额:
$ 5.63万 - 项目类别:
Discovering Eye Tracking Biomarkers of ASD with Diagnostic and Prognostic Power
发现具有诊断和预后能力的 ASD 眼动追踪生物标志物
- 批准号:
10063560 - 财政年份:2019
- 资助金额:
$ 5.63万 - 项目类别:
Discovering Eye Tracking Biomarkers of ASD with Diagnostic and Prognostic Power
发现具有诊断和预后能力的 ASD 眼动追踪生物标志物
- 批准号:
10318939 - 财政年份:2019
- 资助金额:
$ 5.63万 - 项目类别:
Discovering Eye Tracking Biomarkers of ASD with Diagnostic and Prognostic Power
发现具有诊断和预后能力的 ASD 眼动追踪生物标志物
- 批准号:
10532198 - 财政年份:2019
- 资助金额:
$ 5.63万 - 项目类别:
Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
在 1 岁生日时检测 ASD 作为护理标准:Get SET Early 模型
- 批准号:
9320785 - 财政年份:2014
- 资助金额:
$ 5.63万 - 项目类别:
Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
在 1 岁生日时检测 ASD 作为护理标准:Get SET Early 模型
- 批准号:
8758746 - 财政年份:2014
- 资助金额:
$ 5.63万 - 项目类别:
Detection of ASD at the 1st birthday as standard of care: The Get SET Early Model
在 1 岁生日时检测 ASD 作为护理标准:Get SET Early 模型
- 批准号:
8916193 - 财政年份:2014
- 资助金额:
$ 5.63万 - 项目类别:
Early Identification of ASD: Translating Eye Tracking into Practice
自闭症谱系障碍 (ASD) 的早期识别:将眼动追踪转化为实践
- 批准号:
9297357 - 财政年份:2013
- 资助金额:
$ 5.63万 - 项目类别:
Early Identification of ASD: Translating Eye Tracking into Practice
自闭症谱系障碍 (ASD) 的早期识别:将眼动追踪转化为实践
- 批准号:
8852183 - 财政年份:2013
- 资助金额:
$ 5.63万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 5.63万 - 项目类别:
Directed Grant